Week In Review: Bio-Thera Raises $241 Million In Shanghai STAR IPO For Antibody Portfolio
February 15, 2020 at 16:19 PM EST
Bio-Thera Solutions of Guangzhou priced its IPO on Shanghai’s STAR Board to raise $241 million at a valuation of almost $2 billion. The offering, which placed 60 million shares at RMB32.76 each, was reported to be 3,225 times oversubscribed.
